Dendreon

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Dendreon ( DNDN) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients. The stock is trading up 8.9% at $13.45 in recent trading.

Today's Volume: 18 million

Average Volume: 6.8 million

Volume % Change: 268%

From a technical standpoint, shares of DNDN are very close to triggering a big breakout trade if this stock can manage to sustain a move and close above some past overhead resistance at $13.95. A high-volume move and close over $13.95 will push DNDN into position to start filling its massive gap down from back in August of 2010 from over $30.

Volume today is already well above its average action, so watch for a close over $13.95.

If you liked this article you might like

Biotech-Twitter 2014: A Look Back at the Biotech Year Through the Twitter Lens

Where Are They Now? A Look Back at the Best & Worst Biotech CEOs

Nominees for Absolute Worst Biotechnology CEOs of 2014 Are ...

Using Re-Engineered Immune Cells to Kill Leukemia Induces Lasting Remissions

Stock Market Today: S&P 500 Eyes Strong Finish for 2014; Alibaba Spikes